Stock CYTK CYTOKINETICS, INCORPORATED
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Cytokinetics, Incorporated

Equities

CYTK

US23282W6057

Market Closed - Nasdaq
Other stock markets
 16:00:00 2024-05-13 EDT 		5-day change 1st Jan Change
57.89 USD -6.78% Intraday chart for Cytokinetics, Incorporated -11.01% -30.66%
05-09 Oppenheimer Adjusts Cytokinetics Price Target to $106 From $107, Maintains Outperform Rating MT
05-08 Cytokinetics Q1 Net Loss Narrows, Revenue Declines MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
CYTOKINETICS, INCORPORATED Stock Cytokinetics, Incorporated
 6.07B -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 105B
BIONTECH SE Stock BioNTech SE
 22.34B -
ARGENX SE Stock argenx SE
 21.93B -
GENMAB A/S Stock Genmab A/S
 18.59B
  1. Stock Market
  2. Equities
  3. CYTK Stock
  4. Charts Cytokinetics, Incorporated
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW